Myeloproliferative molecular markers detected in granulocytes and in E-CFCs isolated from patients with MPN
| Patient . | Diagnosis . | Thrombosis . | Granulocytes . | E-CFCs . | |||||
|---|---|---|---|---|---|---|---|---|---|
| JAK2 . | SOCS methylation . | HUMARA . | Colonies assayed . | JAK2 . | SOCS methylation . | HUMARA . | |||
| 1 | PMF | No | wt | Yes | Polyclonal | 20 | wt | No | Polyclonal |
| 2 | PMF | No | V617F | No | NE | 7 | wt | No | NE |
| 3 | PMF | No | V617F | Yes | NE | 2 | wt | No | NE |
| 4 | PV | No | V617F | Yes | NE | 3 | wt | No | NE |
| 5 | ET | No | wt | Yes | NE | 10 | wt | No | NE |
| 6 | PMF | No | wt | Yes | NE | 2 | wt | No | NE |
| 7 | PMF | No | V617F | Yes | NE | 14 | wt | No | NE |
| 8 | ET | No | V617F | No | NE | 3 | wt | No | NE |
| 9 | ET | No | V617F | No | Clonal | 7 | wt | No | Polyclonal |
| 10 | PV | No | V617F | No | Clonal | 5 | wt | No | Polyclonal |
| 11 | PV | No | V617F | No | NE | 11 | wt | No | NE |
| 12 | PV | No | V617F | No | Clonal | 2 | wt | No | NE |
| 13 | ET | No | V617F | Yes | NE | 1 | wt | Yes | NE |
| 14 | PV | No | wt | Yes | NE | 3 | wt | Yes | NE |
| 15 | ET | No | V617F | Yes | Polyclonal | 2 | wt | Yes | NE |
| 16 | PMF | No | wt* | Yes | Clonal | 5 | wt* | Yes | Polyclonal |
| 17 | PMF | No | V617F | Yes | NE | 4 | wt | Yes | NE |
| 18 | PMF | PT | V617F | No | Clonal | 21 | V617F | No | Clonal |
| 19 | ET | BCS | V617F | No | Clonal | 10 | V617F | No | Clonal |
| 20 | PMF | PE, DVT | V617F | No | NE | 2 | V617F | No | NE |
| 21 | PMF | DVT | V617F | No | Clonal | 6 | V617F | No | Clonal |
| 22 | PV | Stroke | V617F | No | Clonal | 10 | V617F | No | Clonal |
| Patient . | Diagnosis . | Thrombosis . | Granulocytes . | E-CFCs . | |||||
|---|---|---|---|---|---|---|---|---|---|
| JAK2 . | SOCS methylation . | HUMARA . | Colonies assayed . | JAK2 . | SOCS methylation . | HUMARA . | |||
| 1 | PMF | No | wt | Yes | Polyclonal | 20 | wt | No | Polyclonal |
| 2 | PMF | No | V617F | No | NE | 7 | wt | No | NE |
| 3 | PMF | No | V617F | Yes | NE | 2 | wt | No | NE |
| 4 | PV | No | V617F | Yes | NE | 3 | wt | No | NE |
| 5 | ET | No | wt | Yes | NE | 10 | wt | No | NE |
| 6 | PMF | No | wt | Yes | NE | 2 | wt | No | NE |
| 7 | PMF | No | V617F | Yes | NE | 14 | wt | No | NE |
| 8 | ET | No | V617F | No | NE | 3 | wt | No | NE |
| 9 | ET | No | V617F | No | Clonal | 7 | wt | No | Polyclonal |
| 10 | PV | No | V617F | No | Clonal | 5 | wt | No | Polyclonal |
| 11 | PV | No | V617F | No | NE | 11 | wt | No | NE |
| 12 | PV | No | V617F | No | Clonal | 2 | wt | No | NE |
| 13 | ET | No | V617F | Yes | NE | 1 | wt | Yes | NE |
| 14 | PV | No | wt | Yes | NE | 3 | wt | Yes | NE |
| 15 | ET | No | V617F | Yes | Polyclonal | 2 | wt | Yes | NE |
| 16 | PMF | No | wt* | Yes | Clonal | 5 | wt* | Yes | Polyclonal |
| 17 | PMF | No | V617F | Yes | NE | 4 | wt | Yes | NE |
| 18 | PMF | PT | V617F | No | Clonal | 21 | V617F | No | Clonal |
| 19 | ET | BCS | V617F | No | Clonal | 10 | V617F | No | Clonal |
| 20 | PMF | PE, DVT | V617F | No | NE | 2 | V617F | No | NE |
| 21 | PMF | DVT | V617F | No | Clonal | 6 | V617F | No | Clonal |
| 22 | PV | Stroke | V617F | No | Clonal | 10 | V617F | No | Clonal |
wt indicates wild type; NE, not evaluable; PT, portal vein thrombosis; BCS, Budd-Chiari syndrome; PE, pulmonary embolism; and DVT, deep vein thrombosis of the legs.
This patient carried the MPLK515L mutation.